An endogenous fatty acid amide
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Stearda

Item No. 38973

Technical Information
Formal Name
N-[2-(3,4-dihydroxyphenyl)ethyl]-octadecanamide
CAS Number
105955-10-0
Synonyms
  • N-octadecanoyl Dopamine
  • N-Stearoyl Dopamine
Molecular Formula
C26H45NO3
Formula Weight
Purity
≥95%
Formulation
A solid
Chloroform: Slightly solubleDMSO: SolubleMethanol: Slightly soluble
SMILES
O=C(CCCCCCCCCCCCCCCCC)NCCC1=CC=C(C(O)=C1)O
InChi Code
InChI=1S/C26H45NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-26(30)27-21-20-23-18-19-24(28)25(29)22-23/h18-19,22,28-29H,2-17,20-21H2,1H3,(H,27,30)
InChi Key
KOCSVLPLQCBIGW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Stearda is an endogenous fatty acid amide composed of the catecholamine dopamine (Item Nos. 36532 | 21992) conjugated to the long-chain saturated fatty acid stearic acid (Item No. 10011298).1 It is an inhibitor of 5-lipoxygenase (5-LO; IC50 = 16 nM). Stearda is cytotoxic to K562 chronic myeloid leukemia cells, HOS osteosarcoma fibroblasts, and IMR-32 neuroblastoma cells but not MCF-7 breast cancer cells (IC50s = 36.8, 15, 1.5, and >100 µM, respectively).2 It potentiates calcium influx induced by the arachidonoyl amino acid and cannabinoid 1 (CB1) receptor agonist N-arachidonoyl dopamine (NADA; Item No. 90057) in HEK293 cells expressing human transient receptor potential vanilloid 6 (TRPV6) when used at concentrations of 1 or 10 µM.3 In vivo, stearda (0.1 mg/ml per paw), in combination with NADA, decreases latency to paw withdrawal in the hot plate test in rats.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Iwakami, S., Shibuya, M., Tseng, C.F., et alInhibition of arachidonate 5-lipoxygenase by phenolic compounds. Chem. Pharm. Bull. (Tokyo) 34(9), 3960-3963 (1986).

    2. Akimov, M., Gretskaya, N.M., Zinchenko, G.N., et alCytotoxicity of endogenous lipids N-acyl dopamines and their possible metabolic derivatives for human cancer cell lines of different histological origin. Anticancer Res. 35(5), 2657-2662 (2015).

    3. De Petrocellis, L., Chu, C.J., Moriello, A.S., et alActions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br. J. Pharmacol. 143(2), 251-256 (2004).